As another example, a study of AD-associated presenilin-1 mutation carriers showed that asymptomatic mutation carriers also presented increased cortical thickness in the precuneus and parietotemporal areas 9.9 years prior to the predicted age of disease onset23. This evidence concerns the gene PSEN1 and Alzheimer disease.